Mara Sponseller
Internal Medicine · Cincinnati, OHNPI 1588244628
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AstraZeneca at 33.8% of the total.
Across 70 payments — averaging $26.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$639
- Pfizer$164
- Eisai Inc.$158
- Exact Sciences$141
- Novo Nordisk$137
- AbbVie$114
- plus $534 from 14 others
What the payments were for
- Food & beverage$1,887100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 7 | $639 |
| Pfizer | 8 | $164 |
| Eisai Inc. | 7 | $158 |
| Exact Sciences | 8 | $141 |
| Novo Nordisk | 8 | $137 |
| AbbVie | 5 | $114 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $98 |
| Lilly USA, LLC | 5 | $93 |
| Bayer | 2 | $49 |
| Boehringer Ingelheim | 3 | $48 |
| Corcept Therapeutics | 2 | $43 |
| Merck | 2 | $32 |
| Gilead | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Novartis | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Shield Therapeutics Inc | 1 | $16 |
| Tolmar, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,887 in reported general payments places this provider in the 80th percentile of 4,428 internal medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 20 | $139 |
| Gabapentin | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Cincinnati
- Lisa LarkinCincinnati$276K
- Vincent MartinCincinnati$261K
- Kay JohnsonCincinnati$184K
- Jason HatfieldCincinnati$72K
- Rajbir MinhasCincinnati$62K
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.